Cephalexin Supplier-Buyer Network — Trade Flow Analysis

Name: Cephalexin Supplier-Buyer Trade Network Dataset — 223+ Indian Exporters, 16+ Importers, 104+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Cephalexin supplier network, Cephalexin buyers, pharmaceutical export India, Cephalexin trade data

TransData Nexus

Cephalexin

India Pharmaceutical Trade Intelligence

$349.5M223 Suppliers104 CountriesHS 30042012

ExportsIndia → UNITED STATES82.2%India → SRI LANKA5.2%

ImportsUNITED STATES → India$146.5K CROATIA → India$17.9K

#1 Supplier: ALKEM LABORATORIES #1 Buyer: ASCEND LABORATORIES,

Who Supplies Cephalexin? Top Manufacturers & Buyers 2026 — ALKEM LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1ALKEM LABORATORIES LIMITED

ALKEM LABORATORIES LIMITED is the first-largest Cephalexin exporter from India, with a market share of 65.4% and a total export value of $228.5M across 618 shipments. Their average shipment value of $369.8K is above the market average of $68.3K, suggesting premium or bulk contract pricing.

ALKEM LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ASCEND LABORATORIES, LLC — $98.0M across 265 shipments (42.9% of this supplier's total exports)

• ASCEND LABORATORIES, LLC — $63.0M across 170 shipments (27.5% of this supplier's total exports)

• ASCEND LABORATORIES, LLC — $42.9M across 116 shipments (18.8% of this supplier's total exports)

• ASCEND LABORATORIES, LLC — $18.3M across 50 shipments (8.0% of this supplier's total exports)

• ASCEND LABORATORIES, LLC — $6.4M across 17 shipments (2.8% of this supplier's total exports)

Key Insight: ALKEM LABORATORIES LIMITED's per-shipment value of $369.8K is 441% above the market average of $68.3K, consistent with large-order contracts or value-added formulations.

2LUPIN LIMITED

LUPIN LIMITED is the second-largest Cephalexin exporter from India, with a market share of 6.8% and a total export value of $23.8M across 601 shipments. Their average shipment value of $39.5K is below the market average of $68.3K, reflecting a high-volume, competitive pricing strategy.

LUPIN LIMITED serves 5 named buyers in our database. UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 94.3% of this supplier's tracked business. Top customers include:

• UPS SUPPLY CHAIN SOL — $22.4M across 567 shipments (94.3% of this supplier's total exports)

• LUPIN PHARMA CANADA — $591.5K across 15 shipments (2.5% of this supplier's total exports)

• BOUCHER & MUIR NZ LT — $330.0K across 8 shipments (1.4% of this supplier's total exports)

• BOUCHER & MUIR NZ LT — $279.1K across 7 shipments (1.2% of this supplier's total exports)

• LUPIN PHARMA CANADA — $148.4K across 4 shipments (0.6% of this supplier's total exports)

Key Insight: LUPIN LIMITED operates with high shipment frequency (601 shipments) at a per-shipment value of $39.5K, indicating a broad distribution network with many smaller, regular orders.

3CIPLA LIMITED

CIPLA LIMITED is the third-largest Cephalexin exporter from India, with a market share of 2.7% and a total export value of $9.3M across 184 shipments. Their average shipment value of $50.4K is below the market average of $68.3K, reflecting a high-volume, competitive pricing strategy.

CIPLA LIMITED serves 5 named buyers in our database. BREATHEFREE LANKA PVT LTD is the dominant customer, accounting for 92.9% of this supplier's tracked business. Top customers include:

• BREATHEFREE LANKA PVT LTD — $8.6M across 171 shipments (92.9% of this supplier's total exports)

• BREATHEFREE LANKA PR — $639.3K across 13 shipments (6.9% of this supplier's total exports)

• CAPITAL PHARMACY — $21.7K across 0 shipments (0.2% of this supplier's total exports)

• OPHAM — $1.1K across 0 shipments (0.0% of this supplier's total exports)

• OPHAM ANDRIAMAHAZO B — $643 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: CIPLA LIMITED operates with high shipment frequency (184 shipments) at a per-shipment value of $50.4K, indicating a broad distribution network with many smaller, regular orders.

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the fourth-largest Cephalexin exporter from India, with a market share of 2.1% and a total export value of $7.5M across 294 shipments. Their average shipment value of $25.5K is below the market average of $68.3K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• M/S. SUN PHARMA ANZ PTY LTD — $3.0M across 118 shipments (40.0% of this supplier's total exports)

• M S SUN PHARMA ANZ PTY LIMITED — $2.0M across 79 shipments (26.8% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES SAC — $1.6M across 64 shipments (21.8% of this supplier's total exports)

• M/S. SUN PHARMA ANZ PTY LTD — $499.7K across 20 shipments (6.7% of this supplier's total exports)

• M/S. SUN PHARMA ANZ PTY LTD — $352.6K across 14 shipments (4.7% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (294 shipments) at a per-shipment value of $25.5K, indicating a broad distribution network with many smaller, regular orders.

5STERLING LAB,

STERLING LAB, is the fifth-largest Cephalexin exporter from India, with a market share of 2.0% and a total export value of $6.9M across 37 shipments. Their average shipment value of $186.2K is above the market average of $68.3K, suggesting premium or bulk contract pricing.

STERLING LAB, serves 5 named buyers in our database. TO THE ORDER OF..... is the dominant customer, accounting for 81.9% of this supplier's tracked business. Top customers include:

• TO THE ORDER OF..... — $5.6M across 30 shipments (81.9% of this supplier's total exports)

• TO THE ORDER OF..... — $1.0M across 5 shipments (14.7% of this supplier's total exports)

• TO THE ORDER OF BANK — $194.2K across 1 shipments (2.8% of this supplier's total exports)

• TO THE ORDER OF..... — $33.8K across 0 shipments (0.5% of this supplier's total exports)

• TO THE ORDER OF..... — $9.2K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: STERLING LAB,'s per-shipment value of $186.2K is 173% above the market average of $68.3K, consistent with large-order contracts or value-added formulations.

6AUROBINDO PHARMA LTD

AUROBINDO PHARMA LTD is the fifth-largest Cephalexin exporter from India, with a market share of 1.6% and a total export value of $5.5M across 242 shipments. Their average shipment value of $22.9K is below the market average of $68.3K, reflecting a high-volume, competitive pricing strategy.

AUROBINDO PHARMA LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• AUROLOGISTICS LLC — $1.7M across 74 shipments (30.4% of this supplier's total exports)

• CRONUS PHARMA LLC, — $1.1M across 50 shipments (20.8% of this supplier's total exports)

• AUROLOGISTICS LLC, (AUROBINDO PHARM — $1.1M across 48 shipments (19.7% of this supplier's total exports)

• CRONUS PHARMA LLC, — $1.0M across 45 shipments (18.7% of this supplier's total exports)

• SIVEM PHARMACEUTICALS — $574.4K across 25 shipments (10.4% of this supplier's total exports)

Key Insight: AUROBINDO PHARMA LTD operates with high shipment frequency (242 shipments) at a per-shipment value of $22.9K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Cephalexin imports from India, with a total trade value of $287.1M across 596 shipments — representing a 82.2% share of all Cephalexin exports. The average shipment value of $481.8K is above the global average of $68.3K, indicating high-value procurement contracts or branded formulations. This market is served by 10 tracked buyers.

Named Cephalexin importers in United States: ASCEND LABORATORIES, LLC C/O UPS is the largest buyer, accounting for 34.1% ($98.0M) of this market's total imports.

• ASCEND LABORATORIES, LLC C/O UPS — $98.0M (34.1% of United States's total)

• ASCEND LABORATORIES,LLC — $66.3M (23.1% of United States's total)

• ASCEND LABORATORIES, LLC., — $42.9M (15.0% of United States's total)

Key Insight: United States's per-shipment average of $481.8K (605% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Cephalexin imports from India.

Primary Market

Secondary Market

2Sri Lanka

Sri Lanka ranks as the second-largest destination for Cephalexin imports from India, with a total trade value of $18.1M across 135 shipments — representing a 5.2% share of all Cephalexin exports. The average shipment value of $134.1K is above the global average of $68.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cephalexin importers in Sri Lanka: BREATHEFREE LANKA PVT LTD is the largest buyer, accounting for 50.8% ($9.2M) of this market's total imports.

• BREATHEFREE LANKA PVT LTD — $9.2M (50.8% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $134.1K (96% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Cephalexin imports from India.

Primary Market

Secondary Market

3Australia

Australia ranks as the third-largest destination for Cephalexin imports from India, with a total trade value of $8.4M across 128 shipments — representing a 2.4% share of all Cephalexin exports. The average shipment value of $65.5K is below the global average of $68.3K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Cephalexin importers in Australia: M/S. SUN PHARMA ANZ PTY LTD is the largest buyer, accounting for 45.3% ($3.8M) of this market's total imports.

• M/S. SUN PHARMA ANZ PTY LTD — $3.8M (45.3% of Australia's total)

• M S SUN PHARMA ANZ PTY LIMITED — $2.0M (23.9% of Australia's total)

Key Insight: Australia receives frequent, smaller shipments of Cephalexin — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Australia is a key market for Cephalexin imports from India.

Primary Market

Secondary Market

4Ecuador

Ecuador ranks as the fourth-largest destination for Cephalexin imports from India, with a total trade value of $5.8M across 21 shipments — representing a 1.7% share of all Cephalexin exports. The average shipment value of $276.3K is above the global average of $68.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cephalexin importers in Ecuador: DYVENPRO DISTRIBUCION Y VENTA DE is the largest buyer, accounting for 97.6% ($5.7M) of this market's total imports.

• DYVENPRO DISTRIBUCION Y VENTA DE — $5.7M (97.6% of Ecuador's total)

Key Insight: Ecuador's per-shipment average of $276.3K (305% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ecuador is a key market for Cephalexin imports from India.

Primary Market

Secondary Market

5Tanzania

Tanzania ranks as the fifth-largest destination for Cephalexin imports from India, with a total trade value of $4.9M across 40 shipments — representing a 1.4% share of all Cephalexin exports. The average shipment value of $122.2K is above the global average of $68.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cephalexin importers in Tanzania: MORAF PHARMACEUTICALS LIMITED is the largest buyer, accounting for 34.8% ($1.7M) of this market's total imports.

• MORAF PHARMACEUTICALS LIMITED — $1.7M (34.8% of Tanzania's total)

Key Insight: Tanzania's per-shipment average of $122.2K (79% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Tanzania is a key market for Cephalexin imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cephalexin.
2.Flow Mapping: 223 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,117 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 104 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

5,117 Verified Shipments

223 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Cephalexin

Cephalexin

Who Supplies Cephalexin? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Cephalexin? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Cephalexin Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1ALKEM LABORATORIES LIMITED

2LUPIN LIMITED

3CIPLA LIMITED

4SUN PHARMACEUTICAL INDUSTRIES LIMITED

5STERLING LAB,

6AUROBINDO PHARMA LTD

From Indian Factories to Global Pharmacies — How Cephalexin Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Cephalexin Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Sri Lanka

3Australia

4Ecuador

5Tanzania

People Also Ask — Cephalexin Supplier & Trade Network

Cephalexin Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology